EUVIMEDEUVIMED entdecken
Crossref

Mechanistic Insights into Drug Release from PLGA- and PLA-Based Implants

Dongyue Yu iD, Ryan Schroder, Arnold Teo, Sarah C Traeger, Laura I Mosquera-Giraldo iD, Marc Fancher, France Landry, Yongliang Zhang, Elena Grajales, Christopher G Levins, Xue-Qing Chen, Janet Caceres Cortes iD und 2 weitere

Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5352-5366

DOI: 10.1021/acs.molpharmaceut.6c00399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.09.2026. Verfasst von Dongyue Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Route 206 and Province Line Road, Princeton, New Jersey08540, United States. Hauptthemen laut MEDLINE: Polylactic Acid-Polyglycolic Acid Copolymer, Polyesters, Lactic Acid, Polyglycolic Acid. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biodegradable polymer implants offer long-acting drug delivery, yet the roles of polymer chemistry and drug properties in governing release remain incompletely understood. We hypothesized that polymer viscosity and end-group chemistry regulate water uptake, glass-transition, and chain mobility, thereby controlling implant dissolution and drug release. To test this, drug-loaded implants were fabricated using PLGA and PLA polymers with varied inherent viscosities, lactide/glycolide ratios, and end-group chemistries via vacuum compression molding, and characterized using water-uptake studies, dissolution testing, and NMR analyses. Low-viscosity, acid-terminated polymers showed rapid water uptake and a marked reduction in glass-transition temperature, inducing a transition to a rubbery state with enhanced chain mobility. These changes accelerated implant dissolution and drug release. Drug solubility further modulated drug release: acetaminophen promoted fast dissolution, whereas dexamethasone exhibited slower, polymer-controlled release. The formulations demonstrated a clear in vitro−in vivo relationship, supporting their relevance for preclinical evaluation. Overall, the results establish how polymer chemistry, polymer mobility, and drug physicochemical properties collectively determine release performance, providing a mechanistic basis for designing biodegradable implants with tunable profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polylactic Acid-Polyglycolic Acid CopolymerPolyestersLactic AcidPolyglycolic AcidDrug ImplantsDrug LiberationSolubilityDexamethasoneAnimalsDrug Delivery SystemsViscosityAcetaminophenPolymers

Stichwörter der Autor:innen

In vitro−in vivo relationshipbiodegradable implantsdrug solubilitypolymerpreclinical drug delivery

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerPolyestersDexamethasoneLactic AcidPolyglycolic Acidpoly(lactide)AcetaminophenPolymersDrug Implants

Autor:innen und Institutionen

  • Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Route 206 and Province Line Road, Princeton, New Jersey08540, United States.
  • Discovery Analytical Sciences, Small Molecule Drug Discovery, Research and Early Development, Bristol Myers Squibb, 250 Water Street, Cambridge, Massachusetts02141, United States.
  • Discovery Analytical Sciences, Small Molecule Drug Discovery, Research and Early Development, Bristol Myers Squibb, Route 206 and Province Line Road, Princeton, New Jersey08540, United States.
  • Pharmaceutical Candidate Optimization, Bristol Myers Squibb, 10300 Campus Point Drive Suite 100, San Diego, California92121, United States.
  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
  • Pharmaceutical Candidate Optimization, Bristol Myers Squibb, 250 Water Street, Cambridge, Massachusetts02141, United States.

ORCID-Profile: Dongyue Yu, Laura I Mosquera-Giraldo, Janet Caceres Cortes

Zitieren

APA

Yu, D., Schroder, R., Teo, A., Traeger, S. C., Mosquera-Giraldo, L. I., Fancher, M., Landry, F., Zhang, Y., Grajales, E., Levins, C. G., Chen, X. Q., Caceres Cortes, J., Foster, K. A., & Gesenberg, C. (2026). Mechanistic Insights into Drug Release from PLGA- and PLA-Based Implants. Molecular Pharmaceutics, 23(11), 5352-5366. https://doi.org/10.1021/acs.molpharmaceut.6c00399

Vancouver

Yu D, Schroder R, Teo A, Traeger SC, Mosquera-Giraldo LI, Fancher M, et al. Mechanistic Insights into Drug Release from PLGA- and PLA-Based Implants. Molecular Pharmaceutics. 2026;23(11):5352-5366. doi:10.1021/acs.molpharmaceut.6c00399

BibTeX
@article{Yu2026,
  author = {Yu, Dongyue and Schroder, Ryan and Teo, Arnold and Traeger, Sarah C and Mosquera-Giraldo, Laura I and Fancher, Marc and Landry, France and Zhang, Yongliang and Grajales, Elena and Levins, Christopher G and Chen, Xue-Qing and Caceres Cortes, Janet and Foster, Kimberly A and Gesenberg, Christoph},
  title = {Mechanistic Insights into Drug Release from PLGA- and PLA-Based Implants},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {5352--5366},
  doi = {10.1021/acs.molpharmaceut.6c00399}
}
Kostenlos starten →